LUYE PHARMA Trademark

Trademark Overview


On Tuesday, November 10, 2009, a trademark application was filed for LUYE PHARMA with the United States Patent and Trademark Office. The USPTO has given the LUYE PHARMA trademark a serial number of 79080769. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 11, 2022. This trademark is owned by Shandong Luye Pharmaceutical Co., Ltd.. The LUYE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes and drugs for medical purposes namely, sodium aescinate injections for the treatment of cerebral edema and edema caused by trauma or operations and of venous back flow obstruction diseases, sodium glycididazole injections in the nature of radiosensitizer for the radiotherapy of solid tumors such as head and neck tumor, lung cancer, and esophageal cancer, and reduced glutathione injections for the treatment of alcoholic fatty liver, alcoholic liver fibrosis, alcoholic liver cirrhosis, acute alcoholic hepatitis, poisoning by radiotherapy, drugs and chemicals; medicinal drinks; pharmaceutical preparations, chemico-pharmaceutical preparations, and chemical preparations for pharmaceutical purposes, namely, sodium aescinate tablets for the treatment of venous edema and soft tissue swelling due to various causes, smectite dispersible tablets and smectite powder sachets for the treatment of acute and chronic bacillary diarrhea of adults and children and for the tre...
luye pharma

General Information


Serial Number79080769
Word MarkLUYE PHARMA
Filing DateTuesday, November 10, 2009
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 11, 2022
Registration Number4130180
Registration DateTuesday, April 24, 2012
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 7, 2012

Trademark Statements


Description of MarkThe mark consists of a miscellaneous design on the left, four Chinese characters on the right and the words "LUYE PHARMA" on the top of the Chinese characters.
Goods and ServicesMedicines for human purposes and drugs for medical purposes namely, sodium aescinate injections for the treatment of cerebral edema and edema caused by trauma or operations and of venous back flow obstruction diseases, sodium glycididazole injections in the nature of radiosensitizer for the radiotherapy of solid tumors such as head and neck tumor, lung cancer, and esophageal cancer, and reduced glutathione injections for the treatment of alcoholic fatty liver, alcoholic liver fibrosis, alcoholic liver cirrhosis, acute alcoholic hepatitis, poisoning by radiotherapy, drugs and chemicals; medicinal drinks; pharmaceutical preparations, chemico-pharmaceutical preparations, and chemical preparations for pharmaceutical purposes, namely, sodium aescinate tablets for the treatment of venous edema and soft tissue swelling due to various causes, smectite dispersible tablets and smectite powder sachets for the treatment of acute and chronic bacillary diarrhea of adults and children and for the treatment of pains caused by gullet, stomach and duodenum diseases but not used for spasmolysant, and elcatonin injections for the treatment of bone pains caused by osteoporesis, of hypercalaemia, and of scleromalacia; biological preparations for medical purposes; tonics being medicines, namely, largetrifoliolious bugbane rhizome tablets for the treatment of the pre-menopausal, menopausal and post menopausal syndrome of women, used to relieve the symptoms of hot sweating, restlessness, insomnia, flank pain, dizziness, and tinnitus; gelatin for medical purposes, namely, compound sodium aescinate gel used to relieve the swelling caused by inflammation, degenerative diseases, wounds, ridge pains such as spondylalgia, lumbago, rachialgia, sciatica, closed type acute tissue injuries, lesion in the inter-vertebral disks, varicose of veins, and peritonitis and phlebitis, capsaicin gel used to relieve arthritis and/or muscle pains caused by osteoarthritis, rheumatoid arthritis, myelitis, and fibromyalgia pains caused by sprains to joints; capsules for pharmaceutical purposes, namely, pantoprazole pellets capsules for the treatment of duodenal ulcer, gastric ulcer and acute pathological changes of gastric mucosa, reflux esophagitis and Zollinger-Ellison Syndrome
Indication of Colors claimedColor is not claimed as a feature of the mark.
Transliteration StatementThe non-Latin characters in the mark transliterate to LU YE ZHI YAO and this means GREEN LEAF PHARMACEUTICAL in English.
Translation of Words in MarkThe wording "LUYE" has no meaning in a foreign language.
Disclaimer with Predetermined Text"PHARMA" AND THE NON-LATIN CHARACTERS IN THE MARK WHICH TRANSLITERATE TO ZHI YAO

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShandong Luye Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address 264670
CN

Party NameShandong Luye Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCN

Party NameShandong Luye Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCN

Trademark Events


Event DateEvent Description
Sunday, September 3, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 27, 2023GENERIC MADRID TRANSACTION SENT TO IB
Thursday, July 27, 2023GENERIC MADRID TRANSACTION CREATED
Tuesday, July 11, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 11, 2022CANCELLED SECTION 71
Saturday, April 24, 2021COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, November 28, 2019INTERNATIONAL REGISTRATION RENEWED
Monday, August 12, 2019NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, August 12, 2019REGISTERED-SEC.71 ACCEPTED
Friday, June 21, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, March 14, 2019TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, January 18, 2019POST REGISTRATION ACTION MAILED - SEC.71
Thursday, November 15, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, October 18, 2018TEAS SECTION 71 RECEIVED
Thursday, December 15, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, November 14, 2012NOTIFICATION PROCESSED BY IB
Wednesday, August 29, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 3, 2012FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 2, 2012FINAL DISPOSITION PROCESSED
Tuesday, July 24, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 24, 2012REGISTERED-PRINCIPAL REGISTER
Saturday, February 11, 2012NOTIFICATION PROCESSED BY IB
Tuesday, February 7, 2012PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 18, 2012NOTICE OF PUBLICATION
Wednesday, January 4, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 3, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 29, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 29, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 29, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 21, 2011NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, August 9, 2011NON-FINAL ACTION MAILED
Monday, August 8, 2011NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 19, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 19, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 26, 2011NON-FINAL ACTION MAILED
Tuesday, April 26, 2011NON-FINAL ACTION WRITTEN
Thursday, March 31, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2011ASSIGNED TO LIE
Wednesday, February 23, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 7, 2010NON-FINAL ACTION MAILED
Thursday, October 7, 2010NON-FINAL ACTION WRITTEN
Friday, September 17, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 17, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 17, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 4, 2010REFUSAL PROCESSED BY IB
Tuesday, April 27, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 27, 2010REFUSAL PROCESSED BY MPU
Tuesday, April 27, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, April 26, 2010NON-FINAL ACTION WRITTEN
Friday, April 23, 2010APPLICATION FILING RECEIPT MAILED
Monday, April 19, 2010ASSIGNED TO EXAMINER
Monday, April 19, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 16, 2010LIMITATION OF GOODS/SERVICES FROM IB ENTERED
Thursday, April 15, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB